Die Rekonstitution ist ausschlielich im geeigneten Laborumfeld, aseptisch und nach validiertem Forschungsprotokoll vorgesehen
Dingxi Liu, [email protected] These authors have contributed equally to this work Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
Protocol: BPC-157 250 mcg daily SC + GHK-Cu topical or SC per dermatologic protocol
Product specifications Compound: Tesofensine (research grade) Amount per tablet: 500 MCG Purity: 99%+ (COA-backed) Manufacturing: cGMP manufactured Quantity: 100 tablets per bottle Origin: Ships from Dallas, Texas, USA Intended use: Laboratory, research, and educational purposes only not for human or veterinary use Frequently asked questions What is this product
Youll receive one-on-one care in a chic, private setting designed for total comfort and results-driven healing